REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 90 filers reported holding REATA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $642,600 | +34.6% | 21,000 | +300.0% | 0.01% | +27.3% |
| Q1 2023 | $477,330 | -100.0% | 5,250 | -69.4% | 0.01% | -68.6% |
| Q4 2018 | $964,000,000 | -4.2% | 17,178 | +39.6% | 0.04% | +52.2% |
| Q3 2018 | $1,006,000,000 | -61.2% | 12,304 | -85.2% | 0.02% | -39.5% |
| Q3 2017 | $2,593,000,000 | – | 83,364 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
| Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
| MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
| Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
| Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
| Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
| Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
| Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |